Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

MAGE-A4ᶜ¹º³²T for Multi-Tumor

MAGE-A4ᶜ¹º³²T for Multi-Tumor
Conditions:   Urinary Bladder Cancer;   Melanoma;   Head and Neck Cancer;   Ovarian Cancer;   Non-Small Cell Lung Cancer;   Esophageal Cancer;   Gastric Cancer;   Synovial Sarcoma;   Myxoid Round Cell Liposarcoma
Intervention:   Genetic: Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
Sponsor:   Adaptimmune

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 10, 2019 / by / in